|
|||||
|
|
Ethyl gallate as a novel ERK1/2 inhibitor suppresses patient‐derived esophageal tumor growth |
|
| Authors: | Feifei Liu Xueyin Zu Xiaomeng Xie Kangdong Liu Hanyong Chen Ting Wang Fangfang Liu Ann M. Bode Yan Zheng Zigang Dong Dong Joon Kim |
| Abstract: | |
| Keywords: | ERK1/2 esophageal cancer ethyl gallate patient‐derived xenograft |